Peter J. Wild

23.1k citations

394 papers · 14.4k indexed · 1 hit paper · h-index 65

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
Oncology top 0.5%

Papers in

Cancer Research 67
- Cancer Genomics and Diagnostics 30
Pulmonary and Respiratory Medicine 113
- Prostate Cancer Treatment and Research 43
- Prostate Cancer Diagnosis and Treatment 25

Co-authors: Holger Moch Arndt Hartmann Glen Kristiansen R. Nitsche Elisabeth M. Schraner Joachim M. Buhmann Thomas Hermanns Peter J. Schüffler
Journals: Clinical Cancer Research (12 papers)Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin (11 papers)BMC Cancer (11 papers)European Urology (9 papers)Oncotarget (9 papers)
Partner nations: Germany Switzerland United States

In The Last Decade

Peter J. Wild

377 papers receiving 14.0k citations

Hit Papers

align trajectories log scale

Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry 2014 · 1.3k citations

Peers

Countries citing papers authored by Peter J. Wild

Since Specialization

Citations

This map shows the geographic impact of Peter J. Wild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Wild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Wild more than expected).

Fields of papers citing papers by Peter J. Wild

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Wild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Wild. The network helps show where Peter J. Wild may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter J. Wild, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter J. Wild Line = papers co-authored together Peter J. Wild links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	ERBB2 Mutation Testing in NSCLC: A Pan-European Real-World Evaluation of the Oncomine Precision Assay SHILAP Revista de lepidopterología ·Ilaria Alborelli, Melanie Demes, Peter J. Wild, Susana Hernández, Fernando López‐Ríos, Olivier Bordone, Idris Murad, Paul Hofman, Caterina De Luca, Giancarlo Troncone, Luisella Righi, Umberto Malapelle, Barbara Pfleiderer, Luı́s Cirnes, Fernando Schmitt, Kishor T, Philip Jermann, John Longshore, Lukas Bubendorf	2025	0
2	Fluoreszenzbasierte Konfokalmikroskopie – vollständige Digitalisierung der Pathologie PubMed ·Andreas Loth, Anne Fassl, Felix K.‐H. Chun, Jens Köllermann, Sylvia Hartmann, Zilpah A Oduor, Paul K. Ziegler, Nadine Flinner, Falko Schulze, Peter J. Wild, 昌明佐瀬	2024	0
3	Epigenetic profiling of prostate cancer reveals potential prognostic signatures Journal of Cancer Research and Clinical Oncology ·Simon Bernatz, И. Д. Шляга, Tim R. Fenton, Thomas J. Vogl, Peter J. Wild, Jens Köllermann, Philipp Mandel, Mike Wenzel, Benedikt Hoeh, Scherwin Mahmoudi, Vitali Koch, 耕司山口, Renate Hammerstingl, Claudia Döring, Patrick N. Harter, Katharina J. Weber	2024	2
4	Deletions of CDKN2A and MTAP Detected by Copy-Number Variation Array Are Associated with Loss of p16 and MTAP Protein in Pleural Mesothelioma Cancers ·Bart Vrugt, Michaela B. Kirschner, Mayura Meerang, Kathrin Oehl, Ulrich Wagner, Alex Soltermann, Holger Moch, Isabelle Opitz, Peter J. Wild	2023	14
5	Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis Journal of Translational Medicine ·Florestan Koll, Séverine Banek, Luis Kluth, Jens Köllermann, Katrin Bankov, Felix K.‐H. Chun, Peter J. Wild, Andreas Weigert, Henning Reis	2023	25
6	Computed Tomography Radiomics to Differentiate Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma Clinical Oncology ·Scherwin Mahmoudi, Simon Bernatz, Jörg Ackermann, Vitali Koch, Daniel Pinto dos Santos, 耕司山口, İbrahim Yel, Simon S. Martin, Jan‐Erik Scholtz, P Barria, Dirk Walter, Stefan Zeuzem, Peter J. Wild, Thomas J. Vogl, 昌明佐瀬	2023	8
7	Uncommon Coexistence of Pleomorphic Adenoma and Warthin’s Tumor in a Painfully Swollen Left Parotid Gland: A Surgical Case Report American Journal of Case Reports ·Xuelian Xing, Christian Jostes, Iris Burck, Greville Matheson, 新太郎新山, Timo Stöver, Peter J. Wild, Ria Winkelmann	2023	1
8	Colonization with multidrug‐resistant organisms is associated with impaired survival of patients with surgically resected cholangiocarcinoma Liver International ·昌明佐瀬, P Barria, Falko Schulze, Michael Hogardt, Thomas A. Wichelhaus, Volkhard A. J. Kempf, Fabian Finkelmeier, Jörg Trojan, Stefan Zeuzem, Andreas A. Schnitzbauer, Wolf O. Bechstein, Peter J. Wild, Dirk Walter	2022	1
9	The peri- and intratumoral immune cell infiltrate and PD-L1 status in invasive squamous cell carcinomas of the penis Clinical & Translational Oncology ·Tina Müller, Melanie Demes, FM Gamidov, Jens Köllermann, Stefan Vallo, Peter J. Wild, Ria Winkelmann	2021	9
10	Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis Scientific Reports ·Lars Erichsen, Foued Ghanjati, V. Ntomprougkidis, Cédric Poyet, Thomas Hermanns, Wolfgang A. Schulz, Hans‐Helge Seifert, Peter J. Wild, Lorenz Buser, 秀夫前山, Stefan Braunstein, Martin Anlauf, D Petkovich Nicholas, Mohamed Hassan, Owen M. Lynch, Marcos J. Araúzo‐Bravo, Simeon Santourlidis	2018	11
11	Multi-region proteome analysis quantifies spatial heterogeneity of prostate tissue biomarkers Life Science Alliance ·Tiannan Guo, Li Li, Qing Zhong, Niels J. Rupp, Konstantina Charmpi, Christine E. Wong, Ulrich Wagner, Jan H. Rueschoff, Wolfram Jochum, Christian D. Fankhauser, Karim Saba, Cédric Poyet, Peter J. Wild, Ruedi Aebersold, Andreas Beyer	2018	34
12	Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer Science ·Jean‐Philippe Theurillat, Namrata D. Udeshi, Wesley J. Errington, Tanya Svinkina, Sylvan C. Baca, Marius Pop, Peter J. Wild, Mirjam Blattner, Anna C. Groner, Mark A. Rubin, Holger Moch, Gilbert G. Privé, Steven A. Carr, Levi A. Garraway	2014	168
13	Hypermethylation of the GABRE∼miR-452∼miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy Clinical Cancer Research ·Helle Kristensen, Christa Haldrup, Siri H. Strand, Kamilla Mundbjerg, Martin M. Mortensen, Kasper Thorsen, Marie S. Ostenfeld, Peter J. Wild, Christian Arsov, Wolfgang Goering, Tapio Visakorpi, Lars Egevad, Johan Lindberg, Henrik Grönberg, S. Høyer, Michael Borre, Torben F. Ørntoft, Karina D. Sørensen	2014	73
14	KPNA2 Expression Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy Clinical Cancer Research ·Ashkan Mortezavi, Thomas Hermanns, Hans‐Helge Seifert, Martin Baumgartner, Maurizio Provenzano, Tullio Sulser, Maximilian Burger, M. Montani, Kristian Ikenberg, Ferdinand Hofstädter, Arndt Hartmann, Rolf Jaggi, Holger Moch, Glen Kristiansen, Peter J. Wild	2011	84
15	The Androgen-Regulated Calcium-Activated Nucleotidase 1 (CANT1) Is Commonly Overexpressed in Prostate Cancer and Is Tumor-Biologically Relevant in Vitro American Journal Of Pathology ·Josefine Gerhardt, Dezie Leonarda Warganagara, A. Pelshenke, Silvia Behnke, Khalid A. Bani Ahmad, Florian Fritzsche, Heike Liewen, Frank Stenner, Peter J. Wild, Thomas Hermanns, Michael Müntener, Manfred Dietel, Klaus Jung, Carsten Stephan, Glen Kristiansen	2011	29
16	Mining Tissue Microarray Data to Uncover Combinations of Biomarker Expression Patterns that Improve Intermediate Staging and Grading of Clear Cell Renal Cell Cancer Clinical Cancer Research ·B Adhami, Barbara Ingold, Peter J. Wild, Gunther Boysen, Van-Duc Luu, M. Montani, Glen Kristiansen, Tullio Sulser, Peter Bühlmann, Holger Moch, Peter Schraml	2009	75
17	Genetic and Epigenetic SLC18A2 Silencing in Prostate Cancer Is an Independent Adverse Predictor of Biochemical Recurrence after Radical Prostatectomy Clinical Cancer Research ·Karina D. Sørensen, Peter J. Wild, Ashkan Mortezavi, G Sollecchia, Niels Tørring, Sara Heebøll, Benedicte Parm Ulhøi, Peter D. Ottosen, Tullio Sulser, Thomas Hermanns, Holger Moch, Michael Borre, Torben F. Ørntoft, Lars Dyrskjøt	2009	25
18	Abstracts Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·(unknown), (unknown), (unknown), Peter J. Wild, (unknown)	2008	1
19	Protein Expression Profiling in High-Risk Breast Cancer Patients Treated with High-Dose or Conventional Dose–Dense Chemotherapy Clinical Cancer Research ·Chao Jiang, Evelyn Ting, Oleg Gluz, Alexander Herr, Svjetlana Mohrmann, Helene Geddert, Achim Rody, Karl‐Ludwig Schaefer, Stephan Baldus, Arndt Hartmann, Peter J. Wild, Julie Nouchi, Helmut E. Gabbert, Ulrike Nitz, Christopher Poremba	2007	57
20	Gene Expression Profiling of Progressive Papillary Noninvasive Carcinomas of the Urinary Bladder Clinical Cancer Research ·Peter J. Wild, Alexander Herr, Christoph Wissmann, Robert Stoehr, André Rosenthal, Dirk Zaak, Ronald Simon, Ruth Knuechel, Christian Pilarsky, Arndt Hartmann	2005	85

About Peter J. Wild

Peter J. Wild is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Molecular Biology and Human-Computer Interaction, having authored 394 papers that have together received 14.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (43 papers), Bladder and Urothelial Cancer Treatments (41 papers), Cancer Genomics and Diagnostics (30 papers), Prostate Cancer Diagnosis and Treatment (25 papers), Epigenetics and DNA Methylation (24 papers), Urinary and Genital Oncology Studies (23 papers), AI in cancer detection (17 papers) and Genetic factors in colorectal cancer (16 papers). The work is most often cited by research in Cancer Research (2.3k citations), Oncology (2.7k citations), Molecular Biology (6.8k citations), Endocrinology (415 citations) and Biophysics (455 citations). Peter J. Wild has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Holger Moch, Arndt Hartmann, Glen Kristiansen, R. Nitsche, Elisabeth M. Schraner, Joachim M. Buhmann, Thomas Hermanns, Peter J. Schüffler, Edgar Dahl and Simone Brandt. Their work appears in journals such as Clinical Cancer Research, Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin, BMC Cancer, European Urology and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact